{{Rsnum
|rsid=10811771
|Gene=GFRA3
|Chromosome=9
|position=22770887
|Orientation=plus
|GMAF=0.2658
|Gene_s=GFRA3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 39.8 | 16.8
| HCB | 74.5 | 23.4 | 2.2
| JPT | 46.9 | 47.8 | 5.3
| YRI | 84.4 | 14.3 | 1.4
| ASW | 68.4 | 28.1 | 3.5
| CHB | 74.5 | 23.4 | 2.2
| CHD | 74.3 | 22.9 | 2.8
| GIH | 39.6 | 43.6 | 16.8
| LWK | 84.5 | 15.5 | 0.0
| MEX | 24.1 | 53.4 | 22.4
| MKK | 78.2 | 20.5 | 1.3
| TSI | 31.4 | 53.9 | 14.7
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19875103
|Trait=Response to antipsychotic therapy (extrapyramidal side effects)
|Title=Genomewide Association Study of Movement-Related Adverse Antipsychotic Effects
|RiskAllele=
|Pval=8E-7
|OR=NR
|ORtxt=NR
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10811771
|overall_frequency_n=40
|overall_frequency_d=128
|overall_frequency=0.3125
|n_genomes=28
|n_genomes_annotated=0
|n_haplomes=33
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}